145 related articles for article (PubMed ID: 12209037)
1. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
Font J; García-Carrasco M; Ramos-Casals M; Aldea AI; Cervera R; Ingelmo M; Vives J; Yagüe J
Rheumatology (Oxford); 2002 Sep; 41(9):1025-30. PubMed ID: 12209037
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
[TBL] [Abstract][Full Text] [Related]
3. Analysis of IL10 haplotypes in primary Sjögren's syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies.
Vázquez-Villamar M; Palafox-Sánchez CA; Muñoz-Valle JF; Valle Y; Orozco-Barocio G; Hernández-Bello J; Oregon-Romero E
Hum Immunol; 2015 Jul; 76(7):473-9. PubMed ID: 26074416
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics of primary Sjögren's syndrome in Colombians.
Anaya JM; Mantilla RD; Correa PA
Semin Arthritis Rheum; 2005 Apr; 34(5):735-43. PubMed ID: 15846589
[TBL] [Abstract][Full Text] [Related]
5. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
[TBL] [Abstract][Full Text] [Related]
6. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
Márka M; Bessenyei B; Zeher M; Semsei I
Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
Garcíc-Carrasco M; Font J; Filella X; Cervera R; Ramos-Casals M; Sisó A; Aymamí A; Ballesta AM; Ingelmo M
Clin Exp Rheumatol; 2001; 19(4):411-5. PubMed ID: 11491496
[TBL] [Abstract][Full Text] [Related]
8. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
10. Primary Sjögren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes.
Guggenbuhl P; Jean S; Jego P; Grosbois B; Chalès G; Semana G; Lancien G; Veillard E; Pawlotsky Y; Perdriger A
J Rheumatol; 1998 May; 25(5):900-5. PubMed ID: 9598888
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome.
Limaye V; Lester S; Downie-Doyle S; Pile K; Bardy P; Gordon TP; Rischmueller M
J Rheumatol; 2000 Dec; 27(12):2945-6. PubMed ID: 11128696
[No Abstract] [Full Text] [Related]
12. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
Downie-Doyle S; Bayat N; Rischmueller M; Lester S
Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
14. Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjögren's syndrome.
Ramos-Casals M; Brito-Zerón P; Soria N; Nardi N; Vargas A; Muñoz S; Bové A; Suárez B; Lozano F
Rheumatology (Oxford); 2009 Jan; 48(1):65-9. PubMed ID: 19056797
[TBL] [Abstract][Full Text] [Related]
15. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.
Jean S; Quelvennec E; Alizadeh M; Guggenbuhl P; Birebent B; Perdriger A; Grosbois B; Pawlotsky PY; Semana G
Clin Exp Rheumatol; 1998; 16(6):725-8. PubMed ID: 9844767
[TBL] [Abstract][Full Text] [Related]
16. Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection.
Ramos-Casals M; García-Carrasco M; Cervera R; Filella X; Trejo O; de la Red G; Gil V; Sánchez-Tapias JM; Font J; Ingelmo M
Semin Arthritis Rheum; 2002 Aug; 32(1):56-63. PubMed ID: 12219321
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
Anaya JM; Correa PA; Herrera M; Eskdale J; Gallagher G
J Rheumatol; 2002 Sep; 29(9):1874-6. PubMed ID: 12233881
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus.
Muraki Y; Tsutsumi A; Takahashi R; Suzuki E; Hayashi T; Chino Y; Goto D; Matsumoto I; Murata H; Noguchi E; Sumida T
J Rheumatol; 2004 Apr; 31(4):720-5. PubMed ID: 15088297
[TBL] [Abstract][Full Text] [Related]
19. Primary Sjögren's syndrome in men: clinical and immunological characteristics.
Cervera R; Font J; Ramos-Casals M; García-Carrasco M; Rosas J; Morlà RM; Muñoz FJ; Artigues A; Pallarés L; Ingelmo M
Lupus; 2000; 9(1):61-4. PubMed ID: 10713648
[TBL] [Abstract][Full Text] [Related]
20. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
